共 305 条
[1]
Halon A(2013)ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up Cell Oncol (Dordr) 36 181-190
[2]
Donizy P(2009)The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors J Natl Compr Cancer Netw 7 S1-S29
[3]
Surowiak P(2014)Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer Int. J. Oncol. 45 532-540
[4]
Matkowski R(2012)Biology of bone metastases Cancer Control 19 92-101
[5]
Lipton A(2009)Osteoblasts suppress high bone turnover caused by osteolytic breast cancer in-vitro Exp. Cell Res. 315 2333-2342
[6]
Uzzo R(2014)Yolk sac mesenchymal progenitor cells from New World mice (Necromys lasiurus) with multipotent differential potential PLoS One 9 e95575-29598
[7]
Amato RJ(2010)TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells J. Biol. Chem. 285 29588-332
[8]
Ellis GK(2011)Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin Breast Cancer Res. 13 R106-1696
[9]
Hakimian B(2009)Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells Int. J. Cancer 124 326-13
[10]
Roodman GD(2011)BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231 J. Cancer Res. Clin. Oncol. 137 1687-2464